1 d risk in Bartonella transmission to humans (bartonellosis).

2  an unusual clinical presentation for canine bartonellosis.

3 nducted in a Peruvian community with endemic bartonellosis.

4 lysis using sera from patients with clinical bartonellosis.

5  a patient with the chronic verruga phase of bartonellosis.

6 formance as an aid in the diagnosis of acute bartonellosis.

7 t with the chronic, verruga peruana phase of bartonellosis.

8 r plating for the diagnostic confirmation of bartonellosis.

9  participants were monitored for evidence of bartonellosis.

10              Bartonella bacilliformis causes bartonellosis, a potentially life-threatening emerging i

11 sis of vasoproliferative lesions observed in bartonellosis, and we propose BafA as a key pathogenic f

12                                   In humans, bartonellosis can result in angioproliferative lesions t

13 nt-phase sera, the IFA is positive in 93% of bartonellosis cases.

14 corresponded to the region of endemicity for bartonellosis; however, isolates belonging to two other

15                                      Age and bartonellosis in a family member were the best predictor

16 stigation was performed after an outbreak of bartonellosis in a region of Peru nonendemic for this di

17 and ST8 associated with Cat Scratch Disease (bartonellosis) in humans.

18 uld be considered a diagnostic approach when bartonellosis is suspected.

19 -phase blood samples of laboratory-confirmed bartonellosis patients.

20 cifically associated with three outbreaks of bartonellosis that have recently occurred in areas where

21                Symptoms of acute and chronic bartonellosis were recorded.